2024

1. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial

   BMJ Open, Vol. 14, Núm. 1, pp. e078661